http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0608654-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cdd12cad4de54951829b4952163e20d0
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-616
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
filingDate 2006-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02553b4f3ccccfbed9fc2e1e39b16040
publicationDate 2021-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-PI0608654-C1
titleOfInvention use of 5-amino-1-bd-(5-benzylamino-5-deoxy-1-bd-ribofuranosyl)imidazole-4-carboxamide, 5-amino-1-(5-amino-5-deoxy-bd-ribofuranosyl) imidazol-4-n-[(4-chlorophenyl)methyl]carboxamide or a salt thereof
abstract use of acadesine or a prodrug, analogue, or salt thereof and a blood coagulation inhibitor, pharmaceutical formulation, cardioplegic solution, kit, use of a compound, composition, and use of the composition. the present invention provides methods, compositions, formulations, and kits related to acadesine, or a prodrug, analogue, or salt thereof and/or a blood clotting inhibitor for preventing or reducing adverse effects in a patient. the type of patient who may benefit includes a patient with decreased left ventricular function, a patient with a previous myocardial infarction, a patient undergoing nonvascular surgery, or a fetus during labor and delivery.
priorityDate 2005-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419494600
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420235087
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394678
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17513

Total number of triples: 31.